Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Elementis plc is a global specialty chemicals company specializing in performance-driven additives that enhance formulations for consumer and industrial applications. Operating through two primary business units—Coatings and Personal Care—it supplies high-performance rheology modifiers, antiperspirant actives, and complementary specialty additives to industries including cosmetics, antiperspirants, industrial and architectural coatings, adhesives, sealants, and long-life plastics. The Coatings division supports manufacturers in decorative paints, oil and gas drilling, construction, and energy applications, delivering solutions that improve processing efficiency and sustainability. In Personal Care, Elementis excels as a world leader in rheology technology and the second-largest supplier of antacid compounds in the pharmaceutical industry, aiding smoother skin creams, longer-lasting antiperspirants, and more efficient plant protection products. With approximately 1,000 to 1,500 employees across 19 global locations, the FTSE 250 company, headquartered in London, United Kingdom, emphasizes innovation, unique chemistry, and sustainable outcomes, drawing on nearly 200 years of heritage from its origins as Harrisons & Crosfield. Elementis plays a key role in advancing product performance and environmental goals worldwide.
£1.60
+£0.02 (+1.01%)
EOD Jul 3, 2026
18.24% operating margin is respectable but not wide. ROIC at 7.90%. Suggests the business covers its cost of capital, but doesn't point to a wide moat.
Revenue declined 1.0% YoY. The question is whether this is cyclical or a structural shift.
Free cash flow declined 38% versus the prior year, cash generation momentum has weakened.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
$598M
▼ -1.0% YoY
Net Income (TTM)
-$46M
▲ +4.8% YoY
Op. Margin
18.24%
▲ +2.3pp YoY
ROIC
7.90%
▲ +2.1pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
$51M
▼ -38.3% YoY
Op. Cash Flow (TTM)
$74M
▼ -18.8% YoY
Net Debt
$202M
Cash & Equiv.
$55M
3Y CAGR: -6.7%
3Y CAGR: +5.8%
Continue Research
Elementis (ELM.XLON) trades below a two-stage DCF intrinsic value of about $4.05 per share, so at $1.60 the stock looks undervalued (153.7% below estimated intrinsic value). A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Elementis scores 44/100 on Intrinsiqq's quality scorecard (a mixed business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. It currently yields about 2.0%; see dividend safety for coverage and history. All figures are computed from SEC filings; read the full methodology. This is analysis, not investment advice.
Intrinsiqq's two-stage DCF estimates an intrinsic value of about $4.05 per share for ELM.XLON, projecting its recent free cash flow forward with a growth rate that fades toward a long-run rate and discounting it back to today. Applying a 25% margin of safety gives a more conservative fair-value entry around $3.04. At today's $1.60, that puts the stock about 153.7% below estimated intrinsic value. The result is sensitive to the growth and discount-rate inputs, so it is best to run conservative, base and optimistic cases. You can adjust all of them yourself with the sliders on the DCF tab.
Elementis scores 44 out of 100 on Intrinsiqq's quality score, a weighted blend of 7 metrics each scored 0 to 100, which makes it a mixed business on these measures. Recent fundamentals include a 18.2% operating margin and a 7.9% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
Yes, Elementis pays a regular dividend of about $0.04 per share per year (typically in quarterly installments), a yield of roughly 2.0% at the current price. Elementis has grown the dividend at roughly 34.6% a year over the past few years. A low headline yield is not the same as a weak dividend: what matters is how well earnings and free cash flow cover the payout and whether it is growing, not the percentage alone. For ELM.XLON's full payout history, growth streak and dividend-safety score, see the dividends tab.
That depends on valuation and quality together, not either alone. ELM.XLON currently trades below its estimated intrinsic value and scores 44/100 on quality (mixed). It also yields about 2.0%. A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.